Latest filing published 31 Oct 2019 for Corindus Vascular Robotics, Inc., €444k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +54.3%Entry US$10.12 · Close at T+365 US$15.62
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeffrey Gold: trading record in brief
Jeffrey Gold is a declared insider at 2 companies; the most frequent names are Angiodynamics Inc and Corindus Vascular Robotics, Inc. In total, 37 filings cover trades dated from 20 September 2006 to 29 October 2019.
On the market, this insider has only ever bought: 4 purchases, €26k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 19 share grants and 13 option exercises.
The median purchase comes to €7,367. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
Most recently, on 31 October 2019, the filings show a transaction worth €444k in Corindus Vascular Robotics, Inc. The latest purchase dates back some time: it was published 3,096 days ago, on 18 May 2018. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeffrey Gold
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 115,149 shares@ US$4.2889.2% of flowCommon StockSEC:0001387131-19-008132:0
- 7,057 shares0Common StockSEC:0001567619-19-015033:0
- 6,650 shares@ US$10.6821.9% of flowCommon StockSEC:0001567619-19-014985:0
- 3,276 shares@ US$21.6821.9% of flowCommon StockSEC:0001567619-19-014985:1
- 27,649 shares@ US$2.179.9% of flowCommon StockSEC:0001387131-19-003401:0
- 6,307 shares0Common StockSEC:0001140361-18-033075:0
- 7,000 shares@ US$13.539.8% of flowCommon StockSEC:0001140361-18-032062:0
- 4,004 shares@ US$23.659.8% of flowCommon StockSEC:0001140361-18-032062:1
- 7,000 shares@ US$13.539.8% of flowCommon StockSEC:0001140361-18-029784:0
- 4,228 shares@ US$22.409.8% of flowCommon StockSEC:0001140361-18-029784:1
- 53,326 shares@ US$0.75016.2% of flowCommon StockSEC:0001387131-18-002524:0
- 15,000 shares@ US$0.801.8% of flowCommon StockSEC:0001387131-18-002270:0Canonical exit: 14 Aug 2018 (T+90)
- 9,174 shares0Common StockSEC:0001387131-18-000941:0
- 14,000 shares@ US$15.7517.0% of flowCommon StockSEC:0001140361-17-029123:0
- 12,879 shares@ US$17.1217.0% of flowCommon StockSEC:0001140361-17-029123:1
- 7,976 shares0Common StockSEC:0001140361-17-029123:2
- 9,098 shares@ US$0.761.2% of flowCommon StockSEC:0001387131-16-008206:0Canonical exit: 21 Feb 2017 (T+90)
- 902 shares@ US$0.760.1% of flowCommon StockSEC:0001387131-16-008206:1Canonical exit: 23 Feb 2017 (T+90)
- 12,000 shares@ US$13.2912.8% of flowCommon StockSEC:0001140361-16-079003:0
- 9,642 shares@ US$16.5412.8% of flowCommon StockSEC:0001140361-16-079003:1
- 5,063 shares0Common StockSEC:0001140361-16-073897:0
- 6,000 shares@ US$15.27Common StockSEC:0001140361-15-030136:0
- 5,795 shares@ US$15.81Common StockSEC:0001140361-15-030136:1
- 5,266 shares0Common StockSEC:0001140361-15-028644:0
- 6,000 shares@ US$13.18Common StockSEC:0001140361-14-033027:0
25 of 37 declarations